Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma

Background and purpose: The aim is to investigate whether lumbar skeletal muscle index (LSMI) decreases during treatment of head and neck squamous cell carcinoma (HNSCC) patients, and which pre-treatment variables are associated with change. Materials and methods: The LSMI before and during treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors: Anouk W.M.A. Schaeffers, Hannah A. Scholten, Annemieke Kok, Floris C.J. Reinders, Rebecca K. Stellato, Ernst J. Smid, Maartje A. van Beers, Carla H. van Gils, Caroline M. Speksnijder, Marielle P. Philippens, Lot A. Devriese, Remco de Bree
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Oral Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906025000251
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733734547324928
author Anouk W.M.A. Schaeffers
Hannah A. Scholten
Annemieke Kok
Floris C.J. Reinders
Rebecca K. Stellato
Ernst J. Smid
Maartje A. van Beers
Carla H. van Gils
Caroline M. Speksnijder
Marielle P. Philippens
Lot A. Devriese
Remco de Bree
author_facet Anouk W.M.A. Schaeffers
Hannah A. Scholten
Annemieke Kok
Floris C.J. Reinders
Rebecca K. Stellato
Ernst J. Smid
Maartje A. van Beers
Carla H. van Gils
Caroline M. Speksnijder
Marielle P. Philippens
Lot A. Devriese
Remco de Bree
author_sort Anouk W.M.A. Schaeffers
collection DOAJ
description Background and purpose: The aim is to investigate whether lumbar skeletal muscle index (LSMI) decreases during treatment of head and neck squamous cell carcinoma (HNSCC) patients, and which pre-treatment variables are associated with change. Materials and methods: The LSMI before and during treatment was assessed using MRI scans of HNSCC patients treated with radiotherapy (RT) or chemoradiotherapy (CRT). Mixed models assessed LSMI change and pre-treatment covariates (i.e. age, BMI, tumor characteristics and treatment type). Results: In 63 patients the LSMI decreased from 40.56 cm2/m2 to 39.96 cm2/m2 (p trend = 0.008) on average. The LSMI of CRT patients decreased more than the LSMI of RT patients, but this was not significant (40.85–39.63 cm2/m2 vs. 40.37 to 40.19 cm2/m2; p-interaction = 0.052). No effects of pre-treatment covariates on the LSMI trend over time were observed. Conclusion: LSMI decreased during treatment in HNSCC patients, which was not related to pre-treatment variables, but seemed slightly larger for CRT patients than RT patients.
format Article
id doaj-art-162da3d2f524402c922b394fb0cf119a
institution DOAJ
issn 2772-9060
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Oral Oncology Reports
spelling doaj-art-162da3d2f524402c922b394fb0cf119a2025-08-20T03:07:58ZengElsevierOral Oncology Reports2772-90602025-06-011410073710.1016/j.oor.2025.100737Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinomaAnouk W.M.A. Schaeffers0Hannah A. Scholten1Annemieke Kok2Floris C.J. Reinders3Rebecca K. Stellato4Ernst J. Smid5Maartje A. van Beers6Carla H. van Gils7Caroline M. Speksnijder8Marielle P. Philippens9Lot A. Devriese10Remco de Bree11Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Dietetics, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Oral and Maxillofacial Surgery and Special Dental Care, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the NetherlandsDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Corresponding author. Huispostnummer Q05.4.300, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, the Netherlands.Background and purpose: The aim is to investigate whether lumbar skeletal muscle index (LSMI) decreases during treatment of head and neck squamous cell carcinoma (HNSCC) patients, and which pre-treatment variables are associated with change. Materials and methods: The LSMI before and during treatment was assessed using MRI scans of HNSCC patients treated with radiotherapy (RT) or chemoradiotherapy (CRT). Mixed models assessed LSMI change and pre-treatment covariates (i.e. age, BMI, tumor characteristics and treatment type). Results: In 63 patients the LSMI decreased from 40.56 cm2/m2 to 39.96 cm2/m2 (p trend = 0.008) on average. The LSMI of CRT patients decreased more than the LSMI of RT patients, but this was not significant (40.85–39.63 cm2/m2 vs. 40.37 to 40.19 cm2/m2; p-interaction = 0.052). No effects of pre-treatment covariates on the LSMI trend over time were observed. Conclusion: LSMI decreased during treatment in HNSCC patients, which was not related to pre-treatment variables, but seemed slightly larger for CRT patients than RT patients.http://www.sciencedirect.com/science/article/pii/S2772906025000251ChemoradiotherapyCisplatinSkeletal muscle massChange of muscle massHead and neck oncology
spellingShingle Anouk W.M.A. Schaeffers
Hannah A. Scholten
Annemieke Kok
Floris C.J. Reinders
Rebecca K. Stellato
Ernst J. Smid
Maartje A. van Beers
Carla H. van Gils
Caroline M. Speksnijder
Marielle P. Philippens
Lot A. Devriese
Remco de Bree
Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
Oral Oncology Reports
Chemoradiotherapy
Cisplatin
Skeletal muscle mass
Change of muscle mass
Head and neck oncology
title Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
title_full Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
title_fullStr Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
title_full_unstemmed Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
title_short Change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
title_sort change of skeletal muscle mass and associated factors during radiotherapy and chemoradiotherapy in patients with head and neck squamous cell carcinoma
topic Chemoradiotherapy
Cisplatin
Skeletal muscle mass
Change of muscle mass
Head and neck oncology
url http://www.sciencedirect.com/science/article/pii/S2772906025000251
work_keys_str_mv AT anoukwmaschaeffers changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT hannahascholten changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT annemiekekok changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT floriscjreinders changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT rebeccakstellato changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT ernstjsmid changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT maartjeavanbeers changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT carlahvangils changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT carolinemspeksnijder changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT mariellepphilippens changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT lotadevriese changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma
AT remcodebree changeofskeletalmusclemassandassociatedfactorsduringradiotherapyandchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma